Paolo C. Colombo
Columbia University
345 Papers
1.1K Citations
Paolo C. Colombo is an academic researcher from Columbia University. The author has contributed to research in topics: Ventricular assist device & Medicine. The author has an hindex of 48, co-authored 345 publications. Previous affiliations of Paolo C. Colombo include NewYork–Presbyterian Hospital & Columbia University Medical Center.
Chat about Author
Papers
Use of Durable Continuous-Flow Ventricular Assist Devices in Patients on Immunosuppression.
Robert Sorabella,Jiho Han,Veli K. Topkara,A. Reshad Garan,Melana Yuzefpolskaya,Paolo C. Colombo,Koji Takeda,Yoshifumi Naka,Hiroo Takayama +8 more
TL;DR: Active immunosuppression may lead to a modest increase in postimplant infection rate in durable VAD patients than in non-IS patients undergoing the same treatment; however, late on-device survival is not affected.
Clinical Impact of Hematoma Expansion in Left Ventricular Assist Device Patients.
Kara Melmed,Kara Melmed,G.M. Mondellini,David Roh,Amelia K. Boehme,Soojin Park,Melana Yuzefpolskya,Yoshifumi Naka,Nir Uriel,Sachin Agarwal,E. Sander Connolly,Jan Claassen,Paolo C. Colombo,Joshua Z. Willey +13 more
TL;DR: HE occurrence appears similar between LVAD and non-LVAD patients and HE has a significant impact on LVAD ICH mortality, emphasizing the importance of adequate coagulopathy reversal and blood pressure management in these patients.
Postdischarge Functional Capacity, Health-Related Quality of Life, Depression, Anxiety, and Post-traumatic Stress Disorder in Patients Receiving a Long-term Left Ventricular Assist Device.
Robert N. Sladen,Mark A Shulman,Azka Javaid,Carol L. Hodgson,Paul S. Myles,David C. McGiffin,Shunichi Nakagawa,A.M. Amlani,Jonathan Hupf,Koji Takeda,Yoshifumi Naka,Hiroo Takayama,Peter Bergin,Mark Buckland,Melana Yozefpolskaya,Paolo C. Colombo +15 more
TL;DR: In this paper, the authors designed an observational study to integrate depression, anxiety and post-traumatic stress disorder with functional capacity and health-related quality of life (HR-QOL) in surviving LVAD patients.
Differences Between the Effects of ICDs in Patients Awaiting Heart Transplantation With Pulsatile-Flow and Continuous-Flow LVADs.
TL;DR: It is agreed that implantable cardioverter-defibrillators (ICDs) are an important therapy to maintain for patients with left ventricular systolic dysfunction awaiting heart.